Position in LH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$21,395,360
+$717,589 QoQ
Shares Held
76,412
-1.4% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#108
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $7,240,479,782 across 27 Diagnostics & Research names. LH ranks #15 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
7,271,514 | $3,645,646,251 | |
| 2 | NTRA |
Natera, Inc.
|
2,725,903 | $739,946,367 | |
| 3 | DHR |
Danaher Corp /De/
|
3,687,390 | $702,374,042 | |
| 4 | GH |
Guardant Health, Inc.
|
3,236,065 | $485,506,829 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
2,105,185 | $406,763,838 | |
| 6 | WAT |
Waters Corp /De/
|
809,339 | $303,534,496 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
575,784 | $303,115,723 | |
| 8 | A |
Agilent Technologies, Inc.
|
1,225,769 | $162,818,892 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,395,360 | 76,412 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $20,677,771 | 77,500 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $5,289,299 | 21,083 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $8,801,544 | 30,661 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $9,012,227 | 34,331 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $7,747,445 | 33,288 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,148,690 | 22,452 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $4,656,651 | 20,837 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $3,331,252 | 16,369 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||